However, the exact impact of stroke and chronic cerebral hypoperfusion on tau pathology remains poorly understood, raising a fundamental question about how cerebrovascular diseases influence the accumulation of abnormal proteins, such as tau. This evidence concerns the gene MAPT and stroke disorder.